Tsunami Relief
Google has a page with sites already set up to provide information and handle donations for victims throughout the region of Asia and east Africa where the tsunami hit. Please take a look at the page and see if you can help out in any way.
http://www.google.com/tsunami_relief.html
If you can't help by donating money, you can help by praying. This time of tragedy calls for much prayer. The following are some ways to pray:
Pray for the people affected by this disaster every time you hear about it.
Pray for the healing of the injured.
Pray for the families world-wide who have lost loved ones.
Pray for those people who have lost their homes.
Pray that disease and the spread of disease is avoided.
Pray for the wisdom, safety, and strength of relief workers.
Thank you,
Albert
Saturday, January 08, 2005
Thursday, December 09, 2004
New technology will advance our understanding of the role of complex sugar chains decorating the surface of cells in the body
If you're reading this blog you're aware of the amazing new science called Glycomics that has emerged within the past decade. We are in an age of advanced technology or should I say technological revolution? There are also advanced technologies emerging which enhance and make our lives easier. Below are bits and pieces I copied and pasted on a new technology for understanding sugars on cell surfaces. It's been stated that Glycomics technology is the next Frontier of medicine! ;)
---------------------------
An international consortium of scientists led by Dr. James Paulson of The Scripps Research Institute has created a technology that will advance our understanding of the role of complex sugar chains (glycans or carbohydrates) that decorate the surface of cells in the body.
The technology, known as a functional glycan microarray, is a glass slide onto which are printed hundreds of different glycan chains.
Many proteins involved in communication between cells recognize glycan structures on cell surfaces. The functional glycan microarray will speed research in glycomics, because it will allow scientists to determine to which carbohydrate structures these proteins bind.
Carbohydrate structures are very much a part of the language of life. They are like the accents on spoken words—they change the meaning without changing the spelling. Some even call carbohydrates the third alphabet, behind DNA and proteins.
Read more...
If you're reading this blog you're aware of the amazing new science called Glycomics that has emerged within the past decade. We are in an age of advanced technology or should I say technological revolution? There are also advanced technologies emerging which enhance and make our lives easier. Below are bits and pieces I copied and pasted on a new technology for understanding sugars on cell surfaces. It's been stated that Glycomics technology is the next Frontier of medicine! ;)
---------------------------
An international consortium of scientists led by Dr. James Paulson of The Scripps Research Institute has created a technology that will advance our understanding of the role of complex sugar chains (glycans or carbohydrates) that decorate the surface of cells in the body.
The technology, known as a functional glycan microarray, is a glass slide onto which are printed hundreds of different glycan chains.
Many proteins involved in communication between cells recognize glycan structures on cell surfaces. The functional glycan microarray will speed research in glycomics, because it will allow scientists to determine to which carbohydrate structures these proteins bind.
Carbohydrate structures are very much a part of the language of life. They are like the accents on spoken words—they change the meaning without changing the spelling. Some even call carbohydrates the third alphabet, behind DNA and proteins.
Read more...
Thursday, December 02, 2004
Nutritional Supplements act as sources of radiation protectors
The word 'Nutraceuticals' is becoming the buzz word in quality effective nutritional supplements. Below is a gist of the tip of the iceberg of functional foods (nutraceuticals) yet to come.
Nutritional supplements, including trace elements and several plant materials like soya and amla, have been found to act as excellent sources of radiation protectors, radiation biologists say.
Nutraceuticals as exemplified by flavonoids and isoflavones and nutritional factors such as vitamin E have been demonstrated to have radioprotective properties, Dr V Srinivasan of Armed Forces Radiobiology Research Institute, Bethedsa, US, said at the International Conference on `Recent Trends in Radiation Biology' at BARC here.
"Low toxicity of nutraceuticals and nutritional factors is an advantage over well-known radioprotectors such as amifostine," he said, adding the Institute is working on new molecules like 5-AED and Vitamin E and gemistein are proving to be "very good" radioprotectors .
The word 'Nutraceuticals' is becoming the buzz word in quality effective nutritional supplements. Below is a gist of the tip of the iceberg of functional foods (nutraceuticals) yet to come.
Nutritional supplements, including trace elements and several plant materials like soya and amla, have been found to act as excellent sources of radiation protectors, radiation biologists say.
Nutraceuticals as exemplified by flavonoids and isoflavones and nutritional factors such as vitamin E have been demonstrated to have radioprotective properties, Dr V Srinivasan of Armed Forces Radiobiology Research Institute, Bethedsa, US, said at the International Conference on `Recent Trends in Radiation Biology' at BARC here.
"Low toxicity of nutraceuticals and nutritional factors is an advantage over well-known radioprotectors such as amifostine," he said, adding the Institute is working on new molecules like 5-AED and Vitamin E and gemistein are proving to be "very good" radioprotectors .
Sunday, November 21, 2004
Simple New Blood Test can Determine Severity of Multiple Sclerosis
Glycomics technology is emerging and will eventually become mainstreamed in health care. Below is an example of how Glycomics technology will be used in aiding and enhancing human health.
Glycominds, an Israel Company, wants to give the doctor more options. The Lod-based company's field of expertise is glycomics - that is the behavior of glycans, the sugars that are present in and on the surface of human cells. Genes give instructions to the proteins, but it is the glycans that guide the proteins to their targets and makes sure they do what they are supposed to do.
The multiple sclerosis market is estimated to be worth around $4 billion, notes Dukler.
Glycominds is not limiting its efforts to multiple sclerosis. The company is also looking at developing biomarkers to enable more accurate diagnosis of inflammatory bowel disease, which affects about a million people in the US alone. Glycominds is also looking further afield. "The GlyoChip platform has the ability to identify many other biomarkers," says Dukler. "Inflammatory and autoimmune diseases [like multiple sclerosis] are the initial focus of the company, but it is not limited to that. Glycans play a critical role in many indications."
Read more
Glycomics technology is emerging and will eventually become mainstreamed in health care. Below is an example of how Glycomics technology will be used in aiding and enhancing human health.
Glycominds, an Israel Company, wants to give the doctor more options. The Lod-based company's field of expertise is glycomics - that is the behavior of glycans, the sugars that are present in and on the surface of human cells. Genes give instructions to the proteins, but it is the glycans that guide the proteins to their targets and makes sure they do what they are supposed to do.
The multiple sclerosis market is estimated to be worth around $4 billion, notes Dukler.
Glycominds is not limiting its efforts to multiple sclerosis. The company is also looking at developing biomarkers to enable more accurate diagnosis of inflammatory bowel disease, which affects about a million people in the US alone. Glycominds is also looking further afield. "The GlyoChip platform has the ability to identify many other biomarkers," says Dukler. "Inflammatory and autoimmune diseases [like multiple sclerosis] are the initial focus of the company, but it is not limited to that. Glycans play a critical role in many indications."
Read more
Sunday, November 07, 2004
Time Line- Development of Glycoscience and Glyconutritionals
1880s - Characterization of monosaccharides by Emil Fischer.
1952 - Fresh, not aged, Aloe gel heals radiation burns on rabbits (Clarence C. Lushbaugh, Cancer 1953 vol. 6).
1970 - 500 glycobiology papers published.
1976 - Research paper identifies the 8 sugars found in biological glycoproteins and glycolipids.
1980 - 1500 glycobiology papers published.
1988- Dr. John Axford publishes his "Glucose only theory"
in British Journal (glucose is not the only needed sugar)
1990 - 4000 glycobiology papers published.
1990 - Journal of Glycobiology started by Oxford University.
1990 - "Capitalizing on Carbohydrates" by John Hodgson in BioTechnology Vol 8 Feb. 1990 109 discussing cell surfaces containing carbohydrates involved in intercellular communication and essential for immune function.
1992 - Active component in Aloe gel is stabilized.
1994 - A Research and Development Company is established as a glyconutritional company.
1995 - Nature: cell surface sugars necessary for recognition and immune function.
1996 - Harper's Biochemistry, Murray et al.: chapter on glycoproteins focuses on the 8 necessary sugars used in glycoproteins and glycolipids for cellular communication.
1996 - Patent application is filed for composition and use of a glyconutritional supplement.
1996 - Glyconutritional Company begins marketing glyconutritional supplement.
1998 - Acta Anatomica: special March issue on glycoscience; emphasizes that information content of biological sugar combinations exceeds that of the DNA code.
1998 - South Africa issues world's first patent for a glyconutritional blend
1998 - Healthy humans given radiologically labeled galactose, mannose and glucose incorporate all three directly into glycoproteins, proving that the body uses the different sugars as nutrients directly from the diet, instead of manufacturing them all from glucose alone.
2000 - 8000 glycobiology papers published.
2000 - Launch in March of Health and Nutrition Glycoscience website.
2000 - Newton Graphic Science Magazine: the science of cellular messaging.
2001 - Science: March 23 issue features "Carbohydrates and Glycobiology"; reviews structural and functional uses of 8 critical sugars in cellular physiology.
2001 - Physicians Desk Reference (PDR ) for Non-Prescription Drugs and Dietary Supplements: lists for the first time glyconutrient blend, phytosterol complex, and phytochemical complex.
2001 - Singapore, New Zealand, and Australia issue patents glyconutritional blend
2001 - NIH grants consortium $34 million to study cell-cell communication interactions.
2002 - Australian Journal of Chemistry 55(2): Carbohydrates Special Issue.
2002 - The Scientist 16:9 April 29 "Glycobiology Goes to the Ball."
2002 - Yahoo lists 15,000 entries for the glyconutrient "mannose."
2002 - France, Germany, Ireland, Italy, Liechtenstein, Spain, Switzerland, and the United Kingdom issue patents for a glyconutritional formula
2002 - Scientific American: July "Sweet Medicine: Building Better Drugs from Sugars."
2002 - New Scientist Archive: October story quotes JHU biochemist emphasizing glycobiology as the future of immunology, neurology, developmental biology, and disease research.
2002 - CAM: Volume 2, Issue 5 - December 2002 "Arthritis - Using the New Glyconutritionals."
2003 - Yahoo lists 63,000 entries for the glyconutrient "mannose."
2003 - Mexico and Hong Kong issue patents for a glyconutritional formula.
2003 - Advanced Glyconutrient-Antioxidant formulation is developed.
2004- Taiwan and Philippines issue patents for a glyconutritional formula.
2005- USA issues patent for glyconutritional formula
Subscribe to:
Posts (Atom)